Stock Quote
Pfizer Inc. (PFE.N) (New York Stock Exchange)
$18.36
20 Nov 2009
+1.38%
$18.11
$18.18
19,222,200
$18.47
$18.12
$18.48
$11.62
0.77
41,136,344
PFE.N
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Kindler, Jeffrey | Chairman of the Board, Chief Executive Officer | 13,770,422 |
| Steere, William | Chairman Emeritus | 2,995,440 |
| D'Amelio, Frank | Chief Financial Officer, Senior Vice President | 8,132,350 |
Profile
Pfizer Inc. (Pfizer) is a research-based, global pharmaceutical company. The Company discovers, develops, manufactures and markets prescription medicines for humans and animals. It operates in two business segments: Pharmaceutical and Animal Health. Pfizer also operates several other businesses,... Full Description
Company Address
Pfizer Inc.
235 East 42nd Street
New York NY 10017
P: +1212.7332323
F: +1212.5737851
235 East 42nd Street
New York NY 10017
P: +1212.7332323
F: +1212.5737851
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| The Procter & Gamble Company | $61.80 | -0.35 |
| Johnson & Johnson | $62.31 | +0.37 |
| GlaxoSmithKline plc | £1,253.50 | +13.00 |
| PFE.N | Industry | |
|---|---|---|
| P/E(TTM) | 15.34 | 6.90 |
| P/S(TTM) | 3.23 | 1.54 |
| ROI(TTM) | 7.69 | 6.18 |
| ROE(TTM) | 12.13 | 9.32 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.59 |
| EPS Est. (Current Year) | 2.03 |
| Total Revenue | $11,621.00M |
| Net Income | $2,879.00M |
| EPS | $0.43 |
